Oxidized CaMKII: A "heart stopper" for the sinus node?

Journal of Clinical Investigation

Volumn 121, Issue 8, 2011, Pages 2975-2977

  Huke, Sabine ^a   Knollmann, Björn C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHIONINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AUTOPHOSPHORYLATION; CALCIUM HOMEOSTASIS; CELL DEATH; CYTOPLASM; ENZYME METABOLISM; HEART BEAT; HEART DEPOLARIZATION; HEART FAILURE; HEART PROTECTION; HUMAN; HYPERTENSION; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; SINUS NODE;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL DEATH; ELECTROPHYSIOLOGY; HEART DISEASES; HEART FAILURE; HUMANS; MICE; MODELS, BIOLOGICAL; NADPH OXIDASE; OXYGEN; SINOATRIAL NODE;

EID: 79961006773     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI58389     Document Type: Note

References (18)

1. Lau DH, Roberts-Thomson KC, Sanders P. Sinus node revisited. Curr Opin Cardiol. 2011;26(1):55-59.
2. Evans R, Shaw DB. Pathological studies in sinoatrial disorder (sick sinus syndrome). Br Heart J. 1977;39(7):778-786. (Pubitemid 8143689)
3. Alings AM, Bouman LN. Electrophysiology of the ageing rabbit and cat sinoatrial node - a comparative study. Eur Heart J. 1993;14(9):1278-1288. (Pubitemid 23288300)
4. Swaminathan PD, et al. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest. 2011;121(8):3277-3288.
5. Erickson JR, et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell. 2008;133(3):462-474. (Pubitemid 351608692)
6. Maier LS, Bers DM. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res. 2007;73(4):631-640. (Pubitemid 46227343)
7. Schulman H, Anderson ME. Ca/Calmodulin-dependent protein kinase II in heart failure. Drug Discov Today Dis Mech. 2010;7(2):e117-e122.
8. Ikeda Y, Hoshijima M, Chien KR. Toward biologically targeted therapy of calcium cycling defects in heart failure. Physiology (Bethesda). 2008;23:6-16.
9. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res. 2006;71(2):310-321.
10. Wright SC, Schellenberger U, Ji L, Wang H, Larrick JW. Calmodulin-dependent protein kinase II mediates signal transduction in apoptosis. FASEB J. 1997;11(11):843-849. (Pubitemid 27371893)
11. Fladmark KE, et al. Ca2+/calmodulin-dependent protein kinase II is required for microcystin-induced apoptosis. J Biol Chem. 2002;277(4):2804-2811. (Pubitemid 34953312)
12. Liu Y, Templeton DM. Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. FEBS Lett. 2007;581(7):1481- 1486. (Pubitemid 46452625)
13. Olofsson MH, Havelka AM, Brnjic S, Shoshan MC, Linder S. Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II. BMC Chem Biol. 2008;8:2.
14. Yang Y, et al. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am J Physiol Heart Circ Physiol. 2006;291(6):H3065-H3075. (Pubitemid 44904109)
15. Palomeque J, et al. Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species. Circ Res. 2009;105(12):1204-1212.
16. Cohn JN, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325(5):303-310.
17. Pfeffer MA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327(10):669-677.
18. Sharma D, Buyse M, Pitt B, Rucinska EJ. Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group. Am J Cardiol. 2000;85(2):187-192. (Pubitemid 30026100)